Diaz-Guzman Enrique, Dong Bei, Hobbs Stephen B, Kesler Melissa V, Hayes Don
Department of Internal Medicine, University of Kentucky College of Medicine, Lexington, KY, USA.
Exp Clin Transplant. 2011 Jun;9(3):217-22.
Hemophagocytic lymphohistiocytosis is a rare and often fatal disease that may occur in solid organ transplant recipients. Here, we describe 2 patients who developed hemophagocytic lymphohistiocytosis after having a lung transplant and present a review of all cases of hemophagocytic lymphohistiocytosis occurring in solid organ transplant recipients. Diagnosis of hemophagocytic lymphohistiocytosis relies on the association of clinical findings and the presence of hemophagocytosis. Clinical presentation is nonspecific and patients may present with unexplained sepsis or multiple organ failure. Management consists of treating the underlying process; but unfortunately, the prognosis is poor.
噬血细胞性淋巴组织细胞增生症是一种罕见且常致命的疾病,可发生于实体器官移植受者。在此,我们描述了2例肺移植后发生噬血细胞性淋巴组织细胞增生症的患者,并对实体器官移植受者中发生的所有噬血细胞性淋巴组织细胞增生症病例进行了综述。噬血细胞性淋巴组织细胞增生症的诊断依赖于临床发现与噬血细胞现象的存在。临床表现无特异性,患者可能表现为不明原因的脓毒症或多器官功能衰竭。治疗包括处理潜在病因;但不幸的是,预后较差。